A Study For Treatment Of Paroxysmal Atrial Fibrillation (PAF) With The THERMOCOOL SMARTTOUCH SF Catheter and TRUPULSE Generator

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 149 participants.

Also called NCT05752487

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 149 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05752487
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Austria, Belgium, Denmark, Lithuania (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05752487. Allocation not applicable; no masking; primary purpose treatment. Start 2023-02-27 (actual); primary completion 2023-09-25 (actual). Results posted on 2024-10-16.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study For Treatment Of Paroxysmal Atrial Fibrillation (PAF) With The THERMOCOOL SMARTTOUCH SF Catheter and TRUPULSE Generator
Acronym
SmartfIRE
Intervention (Device)
Pulsed Field (PF) /Radiofrequency (RF) Catheter ablation
Lead sponsor
Biosense Webster, Inc. (class: industry)

Record details

Record id
cardio:ct-nct05752487
Content hash
6f94b906557f46c966f7ca5319e8ee373492a033ed1ad37b2b7dbfa908cb9192